FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to a therapeutic and/or preventive agent for acute and/or chronic pain. Said therapeutic and/or preventive agent contains, as its active agent, a compound based on 1-indansulfamide selected from the group: N-[(1S)-2,2,5,7-tetrafluoro-2,3-dihydro-1H-indene-1-yl]sulfamide, (-)-N-(7-chloro-2,2,5-trifluoro-2,3-dihydro-1H-indene-1-yl)sulfamide, N-[(1S)-2,2-difluoro-7-methyl-2,3-dihydro-1H-indene-1-yl]sulfamide N-[(1S)-2,2,5-trifluoro-7-methyl-2,3-dihydro-1H-indene-1-yl]sulfamide, or its pharmaceutically acceptable salt.
EFFECT: use of the invention provides an analgesic effect in various animal models and may be used for various types of pain.
5 cl, 10 tbl, 9 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW INDANSULFAMIDNOE DERIVATIVES | 2013 |
|
RU2619937C2 |
| TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION | 2007 |
|
RU2456278C2 |
| METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
| PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| PYRANODIPYRIDINE COMPOUND | 2016 |
|
RU2743998C2 |
| COMPOUNDS, ENHANCING GLUTAMATE RECEPTOR, AND THEIR APPLICATION IN MEDICINE | 2005 |
|
RU2403242C2 |
| TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
| PYRIMIDINE COMPOUND AND METHOD FOR ITS PRODUCTION | 2020 |
|
RU2790017C1 |
| ANALOGUES OF 4H-PYRAZOLO[1,5-A]BENZIMIDAZOLE COMPOUNDS AS PARP INHIBITORS | 2015 |
|
RU2672722C2 |
